199 related articles for article (PubMed ID: 10894720)
21. Identification of novel irreversible inhibitors of UDP-N-acetylglucosamine enolpyruvyl transferase (MurA) from Haemophilus influenzae.
Han SG; Lee WK; Jin BS; Lee KI; Lee HH; Yu YG
J Microbiol Biotechnol; 2013 Mar; 23(3):329-34. PubMed ID: 23462005
[TBL] [Abstract][Full Text] [Related]
22. Characterization of a Cys115 to Asp substitution in the Escherichia coli cell wall biosynthetic enzyme UDP-GlcNAc enolpyruvyl transferase (MurA) that confers resistance to inactivation by the antibiotic fosfomycin.
Kim DH; Lees WJ; Kempsell KE; Lane WS; Duncan K; Walsh CT
Biochemistry; 1996 Apr; 35(15):4923-8. PubMed ID: 8664284
[TBL] [Abstract][Full Text] [Related]
23. Computed insight into a peptide inhibitor preventing the induced fit mechanism of MurA enzyme from Pseudomonas aeruginosa.
Lima AH; Dos Santos AM; Alves CN; Lameira J
Chem Biol Drug Des; 2017 Apr; 89(4):599-607. PubMed ID: 27736019
[TBL] [Abstract][Full Text] [Related]
24. Lyme disease enolpyruvyl-UDP-GlcNAc synthase: fosfomycin-resistant MurA from Borrelia burgdorferi, a fosfomycin-sensitive mutant, and the catalytic role of the active site Asp.
Jiang S; Gilpin ME; Attia M; Ting YL; Berti PJ
Biochemistry; 2011 Mar; 50(12):2205-12. PubMed ID: 21294548
[TBL] [Abstract][Full Text] [Related]
25. Cloning and sequencing of Escherichia coli murZ and purification of its product, a UDP-N-acetylglucosamine enolpyruvyl transferase.
Marquardt JL; Siegele DA; Kolter R; Walsh CT
J Bacteriol; 1992 Sep; 174(17):5748-52. PubMed ID: 1512209
[TBL] [Abstract][Full Text] [Related]
26. Characterization of mycobacterial UDP-N-acetylglucosamine enolpyruvyle transferase (MurA).
Xu L; Wu D; Liu L; Zheng Q; Song Y; Ye L; Sha S; Kang J; Xin Y; Ma Y
Res Microbiol; 2014; 165(2):91-101. PubMed ID: 24463011
[TBL] [Abstract][Full Text] [Related]
27. Crystallization and preliminary X-ray crystallographic analysis of UDP-N-acetylglucosamine enolpyruvyl transferase from Haemophilus influenzae in complex with UDP-N-acetylglucosamine and fosfomycin.
Yoon HJ; Ku MJ; Ahn HJ; Lee BI; Mikami B; Suh SW
Mol Cells; 2005 Jun; 19(3):398-401. PubMed ID: 15995357
[TBL] [Abstract][Full Text] [Related]
28. UDP-N-acetylmuramic acid (UDP-MurNAc) is a potent inhibitor of MurA (enolpyruvyl-UDP-GlcNAc synthase).
Mizyed S; Oddone A; Byczynski B; Hughes DW; Berti PJ
Biochemistry; 2005 Mar; 44(10):4011-7. PubMed ID: 15751977
[TBL] [Abstract][Full Text] [Related]
29. UDP-N-acetylglucosamine enolpyruvyl transferase as a potential target for antibacterial chemotherapy: recent developments.
Gautam A; Rishi P; Tewari R
Appl Microbiol Biotechnol; 2011 Oct; 92(2):211-25. PubMed ID: 21822642
[TBL] [Abstract][Full Text] [Related]
30. Boswellic acids, as novel inhibitor targeting peptidoglycan biosynthetic enzyme UDP-N-acetylglucosamine enolpyruvyl transferase (MurA) in Escherichia coli.
Raina D; Khan FG; Tiwari H; Sangwan PL; Nargotra A; Kumar V; Khan IA; Saran S
Arch Microbiol; 2022 Jul; 204(8):472. PubMed ID: 35819545
[TBL] [Abstract][Full Text] [Related]
31. Inhibitory mechanism of novel inhibitors of UDP-N-acetylglucosamine enolpyruvyl transferase from Haemophilus influenzae.
Jin BS; Han SG; Lee WK; Ryoo SW; Lee SJ; Suh SW; Yu YG
J Microbiol Biotechnol; 2009 Dec; 19(12):1582-9. PubMed ID: 20075623
[TBL] [Abstract][Full Text] [Related]
32. High-Level Fosfomycin Resistance in Vancomycin-Resistant Enterococcus faecium.
Guo Y; Tomich AD; McElheny CL; Cooper VS; Tait-Kamradt A; Wang M; Hu F; Rice LB; Sluis-Cremer N; Doi Y
Emerg Infect Dis; 2017 Nov; 23(11):1902-1904. PubMed ID: 29048285
[TBL] [Abstract][Full Text] [Related]
33. Stereochemical course of enzymatic enolpyruvyl transfer and catalytic conformation of the active site revealed by the crystal structure of the fluorinated analogue of the reaction tetrahedral intermediate bound to the active site of the C115A mutant of MurA.
Skarzynski T; Kim DH; Lees WJ; Walsh CT; Duncan K
Biochemistry; 1998 Feb; 37(8):2572-7. PubMed ID: 9485407
[TBL] [Abstract][Full Text] [Related]
34. Evidence of kinetic control of ligand binding and staged product release in MurA (enolpyruvyl UDP-GlcNAc synthase)-catalyzed reactions .
Jackson SG; Zhang F; Chindemi P; Junop MS; Berti PJ
Biochemistry; 2009 Dec; 48(49):11715-23. PubMed ID: 19899805
[TBL] [Abstract][Full Text] [Related]
35. Functional consequence of covalent reaction of phosphoenolpyruvate with UDP-N-acetylglucosamine 1-carboxyvinyltransferase (MurA).
Zhu JY; Yang Y; Han H; Betzi S; Olesen SH; Marsilio F; Schönbrunn E
J Biol Chem; 2012 Apr; 287(16):12657-67. PubMed ID: 22378791
[TBL] [Abstract][Full Text] [Related]
36. Thermodynamic characterization of ligand-induced conformational changes in UDP-N-acetylglucosamine enolpyruvyl transferase.
Samland AK; Jelesarov I; Kuhn R; Amrhein N; Macheroux P
Biochemistry; 2001 Aug; 40(33):9950-6. PubMed ID: 11502190
[TBL] [Abstract][Full Text] [Related]
37. Characterization and inhibition study of MurA enzyme by capillary electrophoresis.
Dai HJ; Parker CN; Bao JJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Jan; 766(1):123-32. PubMed ID: 11820287
[TBL] [Abstract][Full Text] [Related]
38. Investigation of New Inhibitors of UDP-N-Acetylglucosamine Enolpyruvyl Transferase (MurA) by Virtual Screening with Antibacterial Assessment.
Boulhissa I; Chikhi A; Bensegueni A; Ghattas MA; Mokrani EH; Alrawashdeh S; Obaid DEE
Curr Comput Aided Drug Des; 2021; 17(2):214-224. PubMed ID: 32053077
[TBL] [Abstract][Full Text] [Related]
39. Lateral transfers of serine hydroxymethyltransferase (glyA) and UDP-N-acetylglucosamine enolpyruvyl transferase (murA) genes from free-living Actinobacteria to the parasitic chlamydiae.
Griffiths E; Gupta RS
J Mol Evol; 2006 Aug; 63(2):283-96. PubMed ID: 16830093
[TBL] [Abstract][Full Text] [Related]
40. Potential Inhibitors Targeting
Raina D; Kumar C; Kumar V; Khan IA; Saran S
Indian J Microbiol; 2022 Mar; 62(1):11-22. PubMed ID: 35068599
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
